| Entry |
|
| Name |
Sulfacetamide sodium (USP); Bleph (TN); Cetamide (TN); Klaron (TN) |
| Product |
KLARON (Bausch Health US) |
| Generic |
SODIUM SULFACETAMIDE (Oceanside Pharmaceuticals), SULFACETAMIDE SODIUM (A-S Medication Solutions), SULFACETAMIDE SODIUM (Asclemed USA), SULFACETAMIDE SODIUM (Asclemed USA), SULFACETAMIDE SODIUM (Bausch & Lomb Incorporated), SULFACETAMIDE SODIUM (DIRECT RX), SULFACETAMIDE SODIUM (NuCare Pharmaceuticals), SULFACETAMIDE (Pacific Pharma), SULFACETAMIDE SODIUM (Padagis Israel Pharmaceuticals), SULFACETAMIDE SODIUM (Padagis US LLC), SULFACETAMIDE SODIUM (Preferred Pharmaceuticals), SULFACETAMIDE SODIUM (RPK Pharmaceuticals), SULFACETAMIDE SODIUM (Sandoz) |
| Formula |
C8H9N2O3S. Na. H2O
|
| Exact mass |
254.0337
|
| Mol weight |
254.2387
|
| Structure |

|
| Simcomp |
|
| Class |
Antibacterial
DG01787 Sulfonamide antibacterial
DG01784 Short-acting sulfonamide
|
| Remark |
| ATC code: | D10AF06 S01AB04 |
| Chemical structure group: | DG01124 |
| Product (DG01124): | D00871<US> |
| Product (mixture): | D11699<US> |
|
| Efficacy |
Antibacterial, Folic acid biosynthesis inhibitor |
| Disease |
Acne vulgaris [DS:H01445] Trachoma [DS:H00349] |
| Comment |
Sulfonamide
|
| Target |
dihydropteroate synthase [KO:K00796] |
| Pathway |
| ko00790 | Folate biosynthesis |
|
| Interaction |
|
| Structure map |
| map07016 | Sulfonamide derivatives - sulfa drugs |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D10 ANTI-ACNE PREPARATIONS
D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10AF Antiinfectives for treatment of acne
D10AF06 Sulfacetamide
D00871 Sulfacetamide sodium (USP) <US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AB Sulfonamides
S01AB04 Sulfacetamide
D00871 Sulfacetamide sodium (USP) <US>
USP drug classification [BR:br08302]
Antibacterials
Sulfonamides
Sulfacetamide
D00871 Sulfacetamide sodium (USP)
Ophthalmic Agents
Ophthalmic Anti-Infectives
Antibacterials, Ophthalmic
Sulfacetamide Sodium
D00871 Sulfacetamide sodium (USP)
Drug groups [BR:br08330]
Antibacterial
DG01787 Sulfonamide antibacterial
DG01784 Short-acting sulfonamide
DG01124 Sulfacetamide
D00871 Sulfacetamide sodium
Antimicrobials [BR:br08307]
Antibacterials
Folic acid biosynthesis inhibitor
Short-acting sulfonamide
D00871 Sulfacetamide sodium (USP) <US>
Drug groups [BR:br08330]
Antibacterial
DG01787 Sulfonamide antibacterial
DG01784 Short-acting sulfonamide
DG01124 Sulfacetamide
|
| Other DBs |
|
| KCF data |
ATOM 16
1 C8y C 17.9146 -17.3775
2 S4a S 19.1159 -16.6778
3 C8x C 17.9146 -18.7828
4 C8x C 16.7076 -16.6778
5 N1b N 20.3287 -17.3775 #-
6 O3c O 20.1071 -15.6808
7 O3c O 18.1304 -15.6865
8 C8x C 16.7076 -19.4767
9 C8x C 15.4889 -17.3775
10 C5a C 21.5416 -16.6778
11 C8y C 15.4889 -18.7828
12 C1a C 22.7485 -17.3775
13 O5a O 21.5300 -15.2726
14 N1a N 14.2701 -19.4708
15 Z Na 24.4628 -15.5991 #+
16 O0 O 28.1169 -16.9868
BOND 14
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 2 6 2
6 2 7 2
7 3 8 2
8 4 9 1
9 5 10 1
10 8 11 1
11 10 12 1
12 10 13 2
13 11 14 1
14 9 11 2
|